Literature DB >> 2642547

DNA synthesis, blood flow, and glucose utilization in experimental rat brain tumors.

A Watanabe1, R Tanaka, N Takeda, K Washiyama.   

Abstract

The relationships between distribution of deoxyribonucleic acid (DNA)-synthesizing cells (S-phase cells) and blood flow and glucose utilization were investigated in rat brain tumors using an autoradiographic technique and immunoperoxidase staining for bromodeoxyuridine (BUdR). Two strains of rat brain tumor were used: strain A and B, both induced by the Rous sarcoma virus. Strain A was biologically more malignant than strain B. The blood flow was unevenly distributed in the tumor, compared with the contralateral cortex, the average blood flow in the tumor was about 50% in strain A and 60% in strain B. The distribution of blood flow did not correlate with the distribution of S-phase cells or with the distribution of vessels in the tumor in either strain A or B. The average glucose utilization in strain A was about 250% and in strain B about 170% of that of the contralateral cortex. The high glucose utilization area correlated well with the distribution of BUdR-positive nuclei in strain B. These findings suggest that the biological malignancy of a tumor correlates with glucose utilization rather than with blood flow, and that malignant brain tumors show a marked increase in glucose utilization for nucleic acid synthesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642547     DOI: 10.3171/jns.1989.70.1.0086

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.

Authors:  H Minn; R Paul
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

3.  Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.

Authors:  N Takeda; M Diksic
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

4.  Noisy intracranial tumours.

Authors:  B T van Dooren; A C van Bruggen; J J Mooij; J M Hew; H L Journée
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Autoradiographic analysis of [14C]deoxy-D-glucose in thyroid cancer xenografts: a comparative study with pathologic correlation.

Authors:  M Kubota; T Tsuda; T Minase; K Nakada; M Furudate
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

6.  Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods.

Authors:  K Onda; R L Davis; M S Edwards
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

7.  Metabolic patterns in malignant gliomas.

Authors:  J Meixensberger; B Herting; W Roggendorf; H Reichmann
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 8.  Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification.

Authors:  Tamás Nagy; Viktória Fisi; Dorottya Frank; Emese Kátai; Zsófia Nagy; Attila Miseta
Journal:  Cells       Date:  2019-08-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.